ECM Therapeutics
ECM Therapeutics: A regenerative medicine company developing natural biomaterials for disease treatment.
Founded
2018ECM Therapeutics: A regenerative medicine company developing natural biomaterials for disease treatment.
Founded with the mission to revolutionize regenerative medicine, ECM Therapeutics focuses on developing natural biomaterials to treat diseases and injuries. The company specializes in creating diagnostic and therapeutic products derived from extracellular matrix (ECM), a naturally occurring material that influences cell behavior, controls inflammation, and promotes tissue restoration. By harnessing the potent signaling molecules within ECM, ECM Therapeutics aims to provide innovative solutions for tissue repair and regeneration.
ECM Therapeutics has garnered attention for its groundbreaking work in the field of regenerative medicine. The company has attracted notable investors and industry experts who recognize the potential of ECM-based therapies. Key achievements include the successful development of several ECM-based products that have shown promising results in preclinical studies. The overall impact of ECM Therapeutics lies in its potential to transform treatment paradigms for various medical conditions, offering new hope for patients with chronic injuries and diseases.
Companies similar to ECM Therapeutics include ECM Technologies, TissueForm, NeXtGen Biologics and EndoCellutions.
ECM Therapeutics was founded in 2018.
ECM Therapeutics' headquarters is located in Warrendale, PA, US.
ECM Therapeutics' most recent funding round was for $15.9M (USD) in June 2019.
As of Jun 18, 2019, ECM Therapeutics has disclosed funding of $37M (USD). Undisclosed round amounts are excluded.
ECM Therapeutics has 8 employees as of Feb 5, 2024.
endocellutions.com
